|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.24 USD | -0.67% |
|
-0.64% | +6.55% |
| Jan. 15 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Jan. 13 | TD Cowen Adjusts Price Target on Incyte to $128 From $101, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | -0.67% | -0.64% | +6.55% | +45.24% | +16.21% | 20.66B |
- Stock Market
- Equities
- INCY Stock
- Charts Incyte Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
















